Plain-English translation of NCT06134349 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how lithium, a well-established medication for bipolar disorder, works in the brain and why some people respond better to it than others. This study uses a special type of brain imaging called ultra-high-field lithium magnetic resonance imaging to see where and how much lithium accumulates in your brain. By linking these brain images to how well the medication works for you, the researchers hope to one day predict who will benefit most from this treatment.
While lithium has helped many people with bipolar disorder for decades, doctors still cannot easily predict who will respond well to it and who won't — meaning some patients struggle to find the right treatment quickly. This study aims to fill that gap by using advanced imaging to understand the biological reasons behind treatment success or failure.
You likely qualify if…
You likely don't qualify if…
After you have been taking lithium at a stable dose for about four weeks, you will come in for a specialized brain imaging scan (an MRI) to measure how much lithium is in different areas of your brain. You will then be followed for one year, during which researchers will check in to see how well the medication is working for you using standard questionnaires. The study is designed to be observational, meaning researchers are watching and measuring your response to lithium that you're already taking as part of your regular care — not testing a new drug.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Netherlands